These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

665 related items for PubMed ID: 31858534

  • 21. Evaluation of p16/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women.
    Ebisch RM, van der Horst J, Hermsen M, Rijstenberg LL, Vedder JE, Bulten J, Bosgraaf RP, Verhoef VM, Heideman DA, Snijders PJ, Meijer CJ, van Kemenade FJ, Massuger LF, Melchers WJ, Bekkers RL, Siebers AG.
    Mod Pathol; 2017 Jul; 30(7):1021-1031. PubMed ID: 28304400
    [Abstract] [Full Text] [Related]

  • 22. Improved abnormal Pap smear triage using cervical cancer biomarkers.
    Killeen JL, Dye T, Grace C, Hiraoka M.
    J Low Genit Tract Dis; 2014 Jan; 18(1):1-7. PubMed ID: 23760145
    [Abstract] [Full Text] [Related]

  • 23. Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytology.
    Zhang H, Varma KR, Han M, Matsko J, Zhao C.
    Cancer Cytopathol; 2018 Aug; 126(8):525-532. PubMed ID: 29797678
    [Abstract] [Full Text] [Related]

  • 24. Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type.
    Persson M, Elfström KM, Olsson SE, Dillner J, Andersson S.
    PLoS One; 2015 Aug; 10(6):e0127444. PubMed ID: 26083247
    [Abstract] [Full Text] [Related]

  • 25. [The role of HPV E6/E7 mRNA combined with P16/ki67 immunocytochemistry in the diagnosis of atypical squamous cells of undetermined significance(ASCUS)].
    Zhan X, Wang S, Wu X, Qiu X, Li F, Zeng Y, Chen Z.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Oct; 34(10):937-941. PubMed ID: 30554588
    [Abstract] [Full Text] [Related]

  • 26. A prospective study of women with ASCUS or LSIL pap smears at baseline and HPV E6/E7 mRNA positive: a 3-year follow-up.
    Bruno MT, Ferrara M, Fava V, Barrasso G, Panella MM.
    Epidemiol Infect; 2018 Apr; 146(5):612-618. PubMed ID: 29465024
    [Abstract] [Full Text] [Related]

  • 27. The clinical application of HPV E6/E7 mRNA testing in triaging women with atypical squamous cells of undetermined significance or low-grade squamous intra-epithelial lesion Pap smear: A meta-analysis.
    Yang L, Zhu Y, Bai Y, Zhang X, Ren C.
    J Cancer Res Ther; 2017 Apr; 13(4):613-620. PubMed ID: 28901302
    [Abstract] [Full Text] [Related]

  • 28. [Sorting role of p16(INK4a)/Ki-67 double immunostaining in the cervical cytology specimens of ASCUS and LSIL cases].
    Yu J, Zhu HT, Zhao JJ, Su JZ, Xia YD.
    Zhonghua Bing Li Xue Za Zhi; 2017 May 08; 46(5):323-326. PubMed ID: 28468038
    [Abstract] [Full Text] [Related]

  • 29. Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data.
    Uijterwaal MH, Polman NJ, Witte BI, van Kemenade FJ, Rijkaart D, Berkhof J, Balfoort-van der Meij GA, Ridder R, Snijders PJ, Meijer CJ.
    Int J Cancer; 2015 May 15; 136(10):2361-8. PubMed ID: 25345358
    [Abstract] [Full Text] [Related]

  • 30. Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases.
    Byun SW, Lee A, Kim S, Choi YJ, Lee YS, Park JS.
    Int J Med Sci; 2013 May 15; 10(12):1602-7. PubMed ID: 24151431
    [Abstract] [Full Text] [Related]

  • 31. P16/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women.
    Aromseree S, Wongjumpa W, Ekalaksananan T, Temtanakitpaisan A, Kleebkaow P, Srisathaporn S, Tongchai P, Pientong C.
    Asian Pac J Cancer Prev; 2022 Oct 01; 23(10):3405-3411. PubMed ID: 36308365
    [Abstract] [Full Text] [Related]

  • 32. High risk HPV testing in the triage of repeat ASC-US and LSIL.
    Veijalainen O, Tuomisaari S, Luukkaala T, Mäenpää J.
    Acta Obstet Gynecol Scand; 2015 Sep 01; 94(9):931-6. PubMed ID: 26053676
    [Abstract] [Full Text] [Related]

  • 33. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
    Zhang G, Yang B, Abdul-Karim FW.
    Int J Gynecol Pathol; 2015 Mar 01; 34(2):180-6. PubMed ID: 25675189
    [Abstract] [Full Text] [Related]

  • 34. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
    Ferris DG, Wright TC, Litaker MS, Richart RM, Lorincz AT, Sun XW, Borgatta L, Buck H, Kramer L, Rubin R.
    J Fam Pract; 1998 Feb 01; 46(2):125-34. PubMed ID: 9487318
    [Abstract] [Full Text] [Related]

  • 35. Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities.
    Johansson H, Bjelkenkrantz K, Darlin L, Dilllner J, Forslund O.
    PLoS One; 2015 Feb 01; 10(4):e0124460. PubMed ID: 25893988
    [Abstract] [Full Text] [Related]

  • 36. HPV genotyping and p16÷Ki-67 dual staining in the detection of high-grade cervical lesion in patients with LSIL on Pap smear.
    Moleriu LC, Sas I, RaŢiu AC, Margan MM, Secoşan CA, Ilina RŞ, Horhat FG, Stana LG, Grigoraş D, Pirtea LC.
    Rom J Morphol Embryol; 2017 Feb 01; 58(2):433-437. PubMed ID: 28730227
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of p16(INK4a)/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion.
    Waldstrøm M, Christensen RK, Ørnskov D.
    Cancer Cytopathol; 2013 Mar 01; 121(3):136-45. PubMed ID: 22987560
    [Abstract] [Full Text] [Related]

  • 38. A systematic review of p16/Ki-67 immuno-testing for triage of low grade cervical cytology.
    Kisser A, Zechmeister-Koss I.
    BJOG; 2015 Jan 01; 122(1):64-70. PubMed ID: 25208923
    [Abstract] [Full Text] [Related]

  • 39. Repeat cytology and human papillomavirus screening strategies in detecting preinvasive cervical lesions.
    Li K, Yin R.
    Medicine (Baltimore); 2015 Feb 01; 94(5):e435. PubMed ID: 25654377
    [Abstract] [Full Text] [Related]

  • 40. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear.
    Molden T, Nygård JF, Kraus I, Karlsen F, Nygård M, Skare GB, Skomedal H, Thoresen SO, Hagmar B.
    Int J Cancer; 2005 May 10; 114(6):973-6. PubMed ID: 15645423
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.